Specialists from Germany, Italy, the UK and Brussels will speak about tactics to overcome barriers to the prospective billion dollar industry for cannabidiol (CBD) at a a single-day workshop planned Sept. 17 in Germany.
The session, entitled “CBD (cannabidiol) as a meals additive, physique care and pharmaceutical – effects, production, authorization and legislation,” will take location in the Cologne-Bonn Airport, and will run from 10 a.m. to four:30 p.m. The occasion is organized by the nova Institute with help of the European Industrial Hemp Association. Registration is expected.
Featured presenters for the workshop are:
Daniel Kruse, CEO at HempConsult GmbH, Dusseldorf and an EIHA board member. He is a senior advisor to entrepreneurs, startups, investors and other market stakeholders. Kruse, who has been in the hemp market because 1995, is also CEO at Hempro GmbH & Co. KG.
Lorenza Romanese, Managing Director, EIHA, a veteran policy advisor and communication manager at the European level. She has led EIHA’s efforts in Brussels because February 2019, and has worked with a quantity MEPs to propose hemp reforms to the European Union’s Prevalent Agriculture Policy.
Joscha Krauss, CEO at MH healthcare hemp GmbH, Germany, an EIHA member which tends to make CBD and a line of CBD-infused cosmetics. He is active worldwide in the locations of medicinal cannabis and CBD.
Catherine Wilson, CannaWell (UK), who is also an EIHA Board Member.
Though new markets are currently emerging in North America, Israel, Asia and Latin America, Europe is nonetheless struggling to regulate CBD so that secure and legal goods discover their consumers. Amongst important challenges to the sector are current adjustments in the Novel Foods Catalogue that threaten to make specific hemp foods and extracts extra high priced to get to industry, and THC levels allowable in European hemp.